These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 11874743)

  • 1. Baseline visual field characteristics in the ocular hypertension treatment study.
    Johnson CA; Keltner JL; Cello KE; Edwards M; Kass MA; Gordon MO; Budenz DL; Gaasterland DE; Werner E;
    Ophthalmology; 2002 Mar; 109(3):432-7. PubMed ID: 11874743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Ocular Hypertension Treatment Study: topical medication delays or prevents primary open-angle glaucoma in African American individuals.
    Higginbotham EJ; Gordon MO; Beiser JA; Drake MV; Bennett GR; Wilson MR; Kass MA;
    Arch Ophthalmol; 2004 Jun; 122(6):813-20. PubMed ID: 15197055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Calculation in the Medication Arm of the Ocular Hypertension Treatment Study.
    Leshno A; De Moraes CG; Cioffi GA; Kass M; Gordon M; Liebmann JM
    Ophthalmol Glaucoma; 2023; 6(6):592-598. PubMed ID: 37336266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine Learning-Derived Baseline Visual Field Patterns Predict Future Glaucoma Onset in the Ocular Hypertension Treatment Study.
    Singh RK; Smith S; Fingert J; Gordon M; Kass M; Scheetz T; Segrè AV; Wiggs J; Elze T; Zebardast N
    Invest Ophthalmol Vis Sci; 2024 Feb; 65(2):35. PubMed ID: 38393715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot study comparing a new virtual reality-based visual field test to standard perimetry in children.
    Mesfin Y; Kong A; Backus BT; Deiner M; Ou Y; Oatts JT
    J AAPOS; 2024 Jun; 28(3):103933. PubMed ID: 38729256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual field progression patterns in the ocular hypertension treatment study correspond to vulnerability regions of the disc.
    Leshno A; Bommakanti N; De Moraes CG; Gordon MO; Kass MA; Cioffi GA; Liebmann JM
    Eye (Lond); 2024 Jun; 38(8):1549-1555. PubMed ID: 38355667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between visual field loss and contrast threshold elevation in glaucoma.
    Tochel CM; Morton JS; Jay JL; Morrison JD
    BMC Ophthalmol; 2005 Sep; 5():22. PubMed ID: 16159386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeatability of a Virtual Reality Headset Perimeter in Glaucoma and Ocular Hypertensive Patients.
    Nascimento E Silva R; Kim JA; Li Y; Chen C; Chaudhry AF; Berneshawi AR; Zhang M; Villarreal A; Liu J; Shue A; Chang DS; Chang RT
    Transl Vis Sci Technol; 2024 Jun; 13(6):14. PubMed ID: 38899952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual function in human ocular toxoplasmosis.
    Scherrer J; Iliev ME; Halberstadt M; Kodjikian L; Garweg JG
    Br J Ophthalmol; 2007 Feb; 91(2):233-6. PubMed ID: 16987904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability of Visual Field Testing in a Telehealth Setting Using a Head-Mounted Device: A Pilot Study.
    McLaughlin DE; Savatovsky EJ; O'Brien RC; Vanner EA; Munshi HK; Pham AH; Grajewski AL
    J Glaucoma; 2024 Jan; 33(1):15-23. PubMed ID: 37647317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Airborne COVID-19 Transmission While Performing Humphrey Visual Field Testing.
    Jain N; Kaur S; Kopsachilis N; Zia R
    J Glaucoma; 2021 Mar; 30(3):219-222. PubMed ID: 33394847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Associated with Topical Medication Instillation Failure in Glaucoma: VRAMS-QPiG Study.
    Tanito M; Mochiji M; Tsutsui A; Harano A; Ichioka S; Takayanagi Y; Kataoka Y; Takagi Y; Shii D
    Adv Ther; 2023 Nov; 40(11):4907-4918. PubMed ID: 37707675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Far Nasal Part of the Visual Field - Part I.
    Lešták J; Fůs M; Lešták T; Pitrová Š
    Cesk Slov Oftalmol; 2023; 79(6):306-309. PubMed ID: 38086702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting glaucoma before onset using a large language model chatbot.
    Huang X; Raja H; Madadi Y; Delsoz M; Poursoroush A; Kahook MY; Yousefi S
    Am J Ophthalmol; 2024 May; ():. PubMed ID: 38823673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Associated With Visual Field Testing Reliability in Children With Glaucoma or Suspected Glaucoma.
    Kumar A; Hekmatjah N; Yu Y; Han Y; Ying GS; Oatts JT
    Am J Ophthalmol; 2024 Apr; 264():187-193. PubMed ID: 38614194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study of the outcomes of human trafficking survivors assessment with girls who have experienced commercial sexual exploitation.
    Helpingstine C; Kenny MC; Rubiales R
    Eval Program Plann; 2024 Jun; 106():102462. PubMed ID: 38889549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. INDUCED ELEVATION OF INTRA-OCULAR PRESSURE AND THE VISUAL FIELD.
    Bietti GB
    Br J Ophthalmol; 1965 Apr; 49(4):222. PubMed ID: 18170866
    [No Abstract]   [Full Text] [Related]  

  • 18. Errors in statistical analysis and questionable randomization lead to unreliable conclusions.
    George BJ; Brown AW; Allison DB
    J Paramed Sci; 2015; 6(3):153-154. PubMed ID: 26949506
    [No Abstract]   [Full Text] [Related]  

  • 19. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.
    Kass MA; Heuer DK; Higginbotham EJ; Johnson CA; Keltner JL; Miller JP; Parrish RK; Wilson MR; Gordon MO
    Arch Ophthalmol; 2002 Jun; 120(6):701-13; discussion 829-30. PubMed ID: 12049574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glaucoma Hemifield Test. Automated visual field evaluation.
    Asman P; Heijl A
    Arch Ophthalmol; 1992 Jun; 110(6):812-9. PubMed ID: 1596230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.